Citadel Advisors - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 91 filers reported holding SURFACE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q1 2023$85,569
-84.5%
122,452
-81.8%
0.00%
Q4 2022$551,538
-63.2%
672,607
-53.3%
0.00%
Q3 2022$1,499,000
-37.9%
1,441,336
-2.1%
0.00%
-100.0%
Q2 2022$2,414,000
-45.3%
1,471,946
-1.9%
0.00%0.0%
Q1 2022$4,411,000
-41.1%
1,500,516
-4.3%
0.00%0.0%
Q4 2021$7,494,000
-38.3%
1,567,836
-2.3%
0.00%
-50.0%
Q3 2021$12,147,000
-16.5%
1,604,743
-17.7%
0.00%
-33.3%
Q2 2021$14,543,000
+66.7%
1,949,488
+74.3%
0.00%
+50.0%
Q1 2021$8,725,000
+407.3%
1,118,749
+500.9%
0.00%
Q4 2020$1,720,000
+1174.1%
186,175
+854.7%
0.00%
Q3 2020$135,000
-74.4%
19,500
-93.1%
0.00%
Q1 2020$528,000
-0.9%
282,130
-0.5%
0.00%
Q4 2019$533,000
+32.6%
283,595
+0.3%
0.00%
Q3 2019$402,000
-52.0%
282,654
-4.9%
0.00%
Q2 2019$838,000
-60.9%
297,121
-33.8%
0.00%
-100.0%
Q1 2019$2,141,000
-27.3%
448,833
-35.4%
0.00%
-50.0%
Q4 2018$2,946,000
-74.6%
694,794
-34.3%
0.00%
-60.0%
Q3 2018$11,577,000
-18.0%
1,058,252
+22.2%
0.01%
-28.6%
Q2 2018$14,119,000865,7190.01%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 2,945,453$2,061,8179.68%
DAFNA Capital Management LLC 1,100,000$768,6800.23%
TANG CAPITAL MANAGEMENT LLC 1,300,000$908,4400.14%
EcoR1 Capital, LLC 3,082,959$2,154,3720.07%
ARK Investment Management 5,496,146$3,840,7070.03%
Forefront Analytics, LLC 61,156$42,7370.02%
GSA CAPITAL PARTNERS LLP 230,292$1610.02%
CORNERCAP INVESTMENT COUNSEL INC 113,219$79,1170.01%
Knights of Columbus Asset Advisors LLC 157,769$110,2490.01%
Nikko Asset Management Americas, Inc. 999,026$649,3670.01%
View complete list of SURFACE ONCOLOGY INC shareholders